For the quarter ending 2026-03-31, WST has $4,109,800K in assets. $1,119,400K in debts. $521,400K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 521,400 | 791,300 | 628,500 | 509,700 |
| Accounts receivable, net | 685,600 | 574,400 | 625,000 | 582,400 |
| Inventories | 452,600 | 443,900 | 438,000 | 421,100 |
| Other current assets | 167,200 | 168,600 | 131,800 | 167,700 |
| Total current assets | 1,826,800 | 1,978,200 | 1,823,300 | 1,680,900 |
| Property, plant and equipment | 3,223,000 | 3,223,400 | 3,232,900 | 3,177,600 |
| Less accumulated depreciation and amortization | 1,520,800 | 1,497,000 | 1,492,300 | 1,455,600 |
| Property, plant and equipment, net | 1,702,200 | 1,726,400 | 1,740,600 | 1,722,000 |
| Operating lease right-of-use assets | 110,200 | 117,000 | 97,800 | 104,400 |
| Investments in affiliated companies | 209,200 | 212,300 | 220,900 | 224,700 |
| Goodwill | 109,200 | 109,900 | 110,600 | 110,900 |
| Intangible assets, net | 7,000 | 7,700 | 8,900 | 9,700 |
| Deferred income taxes | 63,900 | 38,400 | 27,900 | 29,700 |
| Other noncurrent assets | 81,300 | 80,100 | 75,800 | 70,500 |
| Total assets | 4,109,800 | 4,270,000 | 4,105,800 | 3,952,800 |
| Accounts payable | 252,300 | 253,700 | 255,800 | 239,000 |
| Accrued salaries, wages and benefits | 72,600 | 135,900 | 111,800 | 93,400 |
| Income taxes payable | 78,900 | 28,100 | 33,300 | 28,500 |
| Operating lease liabilities | 21,400 | 22,700 | 21,400 | 20,900 |
| Accrued commissions, rebates and royalties | 46,600 | - | - | - |
| Other current liabilities | 202,200 | 214,500 | 213,100 | 222,800 |
| Total current liabilities | 674,000 | 654,900 | 635,400 | 604,600 |
| Long-term debt | 202,800 | 202,800 | 202,700 | 202,600 |
| Deferred income taxes | 22,700 | 23,000 | 22,800 | 23,000 |
| Pension and other postretirement benefits | 28,500 | 29,000 | 31,100 | 30,800 |
| Operating lease liabilities | 92,000 | 95,600 | 73,500 | 79,800 |
| Deferred compensation benefits | 11,800 | 13,500 | 13,500 | 12,500 |
| Other long-term liabilities | 87,600 | 75,200 | 75,300 | 70,400 |
| Total liabilities | 1,119,400 | 1,094,000 | 1,054,300 | 1,023,700 |
| Preferred stock, 3.0million shares authorized 0 shares issued and outstanding | 0 | - | 0 | 0 |
| Common stock, par value 0.25 per share 200.0 million shares authorized shares issued march31, 2026 - 75.3million, december31, 2025 - 75.3 million shares outstanding march31, 2026 - 70.9million, december31, 2025 - 72.0 million | 18,800 | 18,800 | 18,800 | 18,800 |
| Capital in excess of par value | 0 | 0 | 0 | 0 |
| Retained earnings | 4,475,900 | 4,374,900 | 4,262,400 | 4,139,200 |
| Accumulated other comprehensive loss | -125,200 | -105,500 | -102,300 | -88,700 |
| Treasury stock, at cost (march31, 2026 - 4.4million shares, december31, 2025 - 3.3 million shares) | 1,379,100 | 1,112,200 | 1,127,400 | 1,140,200 |
| Total equity | 2,990,400 | 3,176,000 | 3,051,500 | 2,929,100 |
| Total liabilities and equity | 4,109,800 | 4,270,000 | 4,105,800 | 3,952,800 |
WEST PHARMACEUTICAL SERVICES INC (WST)
WEST PHARMACEUTICAL SERVICES INC (WST)